Login to Your Account



FATALITY RATE EDGES UP TO 42.8%

Researchers identify new candidate for MERS treatment

By John Fox
Staff Writer

Wednesday, February 5, 2014

HONG KONG – A collaborative team from Hong Kong and mainland China has discovered an antiviral peptide that is a promising candidate for treating patients infected with the emergent Middle East respiratory syndrome (MERS) coronavirus, for which there are currently no effective treatments.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription